期刊文献+

心衰患者基础左室射血分数影响心脏再同步化治疗疗效的分析 被引量:7

Effect of baseline left ventricular ejection fractions impact on the outcome of cardiac resynchronization therapy in patients with heart failure
下载PDF
导出
摘要 目的:研究心衰患者基础左室射血分数(LVEF)对心脏再同步化治疗(CRT)疗效的影响。方法:回顾分析CRT治疗心力衰竭54例(男31例,女23例),平均年龄(59.93±9.42)岁。根据LVEF将患者分为A组(LVEF≤35%)和B组(LVEF>35%),术后随访症状、超声和心衰恶化引起的主要不良事件,比较手术前后心功能分级、LVEF变化及CRT反应率。结果:术后两组心功能分级改善程度无差异。术后3个月和12个月A组LVEF增幅显著高于B组[(5.08±2.81)%vs(2.45±1.80)%,P<0.05;(5.38±2.92)%vs(2.39±3.53)%,P<0.05]。A组CRT反应率显著高于B组(66.1%vs 33.9%,P<0.05;81.25%vs47.83%,P<0.05)。术后12个月两组LVED均减小,临床不良事件发生无差异。结论 :CRT总体疗效显著,LVEF≤35%心衰患者CRT反应率较高,术后心功能改善明显。 Objective To investigate the effect of baseline Left-ventricular ejection fraction (LVEF) on the cardiac resynchronization therapy (CRT). Methods A retrospective analysis of patients with heart failure was performed. Fifty-four patients [aged (59.73 ± 11.61)years, 31 males, 23 females] who underwent CRT/CRTD were divided into 2 groups according to LVEF ( group A, LVEF≤ 35%; group B, LVEF 〉 35% ). NYHA class, LVEF,CRT respond rates and medical adverse event (MAE) due to worsening heart failure were detected at 3 and 12 months post-surgery. Results The score of NYHA class changing wasn′t different between these two group. Compared to group B, LVEF was markedly increased (5.08 ± 2.81)% vs (2.45 ± 1.80)%, P 〈 0.05;(5.38 ± 2.92)% vs (2.39 ± 3.53)%, P 〈 0.05)at 3 and 12 months post-surgery. Similarly, group A owned high CRT response rates(66.1% vs 33.9%, P 〈 0.05; 81.25% vs 47.83%, P 〈 0.05) at the both two time points. At 12 months post-surgery , LVED decreased and the MAE was similar in all groups. Conclusion Patients with EF≤ 35% have more increases in LVEF and own high CRT response rates post-CRT.
出处 《实用医学杂志》 CAS 北大核心 2015年第12期1939-1941,共3页 The Journal of Practical Medicine
基金 安徽省科技计划项目(编号:1301042210)
关键词 心力衰竭 心脏再同步化治疗 左室射血分数 Heart failure Cardiac resynchronization therapy Left ventricular ejection fractions
  • 相关文献

参考文献14

  • 1杨震,于欣,贾绍斌,于美玲,纳丽莎,徐方芳,吕剑锋,刘郎,陈乾,王竟靖,王学忠,沙勇.心脏再同步化治疗对失同步化缺血性心力衰竭心肌内向整流钾电流的影响[J].实用医学杂志,2013,29(5):721-723. 被引量:5
  • 2Thebault C, Donal E, Meunier C, et al. Sites of left and right ventricular lead implantation and response to cardiac rcsynchro- nization therapy observations from the REVERSE trial [J]. Euro Heart J, 2012,33 (21 ) : 2662-2671.
  • 3van Gelder BM, Brackc FA. Acute Hemodynamic Effects of Single and Dual Site Left Ventricular Pacing Employing a Dual Cathodal Coronary Sinus Lead [J]. PACE, 2015,38 (5) : 558- 564.
  • 4Behar JM, Bostock J, Po Zhu Li A, et al. Cardiac resynchro- nization therapy delivered via a muhipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: Long-term follow-up from a multicenter reg- istry [J]. J Cardiovasc Eleetrophysiol, 2015,26 (5) : 540-546.
  • 5Kutyifa V, Kloppe A, Zareba W, et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automat- ic Defibrillator Implantation Trial With Cardiac Resynchroniza- tion Therapy) [J]. JACC, 2013,61(9):936-944.
  • 6Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study [J]. Euro Heart J, 2013,34(33) :2592-2599.
  • 7Gierula J, Cubbon RM, Jamil HA, et al. Cardiac resynchro- nization therapy in pacemaker-dependent patients with lefl ven- tricular dysfunction [ J ]. Europace, 2013,15 ( 11 ) : 1609 - 1614.
  • 8桂春,朱立光.心脏再同步化治疗轻度慢性心力衰竭的疗效观察[J].广西医学,2012,34(4):422-424. 被引量:2
  • 9Zecchin M, Proclemer A, Magnani S, et al. Long-term out- come of "super-responder" patients to cardiac resynchronization therapy [J]. Europace, 2014,16(3) :363-371.
  • 10Linde C, Daubert C, Abraham WT, et al. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure [J]. Circ Heart Fail, 2013,6(6): 1180-1189.

二级参考文献13

  • 1Klein HU. Cardiac resynchronization therapy in asympto- matic or mildly symptomatic heart failure patients[ J]. Curt Treat Options Cardiovasc Med,2010,12 (5) :431 - 442.
  • 2Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart fail- ure patients and in asymptomatic patients with left ventric- ular dysfunction and previous heart failure symptoms [ J ]. J Am Coll Cardiol,2008,52 (23) : 1 834 - 1 843.
  • 3Linde C, Abraham WT, Gold MR, et al. Cardiac resynchro- nization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology:results from the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) study[ J]. J Am Coll Cardiol,2010,56(22) :1 826 - 1 831.
  • 4Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynehronization therapy in patients with asymptomatic or mildly symptomatic left ven- tricular dysfunction:insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial [ J ]. J Am Coil Cardiol,2009,54(20) :1 837-1 846.
  • 5Ypenburg C, Lancellotti P, Tops LF, et al. Acute effects of initiation and withdrawal of cardiac resynchronization ther- apy on papillary muscle dyssynchrony and mitral regurgita- tion[J]. J Am Con Cardiol,2007,50(21 ) :2 071 -2 077.
  • 6Stavrakis S,Lazzara R,Thadani U. The benefit of cardiac re- synchronization therapy and QRS duration: a meta-analysis [ J ]. J Cardiovasc Electrophysiol, 2012,23 (2) : 163 - 168.
  • 7Nattel S, Maguy A, Le Bouter S, et al. Arrhythmogenie ion- channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation [J]. Physiol Rev, 2007,87 (2) :425-456.
  • 8Tsuji Y, Zicha S, Qi X Y, et al. Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia:discrete arrhythmogenic consequences related to differential delayed rectifier changes [J]. Circulation, 2006, 113(3) : 345-355.
  • 9Aiba T, Hesketh G G, Barth A S, et al. Electrophysiologieal consequences of dyssynchronous heart failure and its restoration by resynchronization therapy [J]. Circulation, 2009,119 (9) : 1220-1230.
  • 10Zaca V, Baiocchi C, Gaddi R, et al. Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with β-blockers [J]. J Cardiovasc Med(Hagerstown), 2011,12(4) : 227-233.

共引文献5

同被引文献34

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部